Source-reported fields
Expense method: A
Literal source text
General issues related to Medicare and Medicaid, including: Part D Medicare Program; CMMI Drug Pricing Demonstration Programs; drug pricing; Alzheimers Screening and Prevention Act (ASAP) (HR 6130, S 3267); Concentrating on High-value Alzheimers Needs to Get to an End Act (CHANGE) (HR 4752. S 2379).
Literal federal measure citations: HR 6130, S 3267, HR 4752, S 2379
Issues related to tax reform; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.
Literal federal measure citations: H.R.1
Issues related to supply chain manufacturing and tariffs; Section 232 tariff investigation on branded pharmaceuticals.
Issues related to pharmaceutical Intellectual Property (IP).
Issues related to pharmaceutical manufacturing.
Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; pharmaceutical scheduling; TRICARE coverage issues in FY2027 National Defense Authorization Act; PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
Literal federal measure citations: S.891
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
